Dr. Joseph Nathan, MD, MSc is the Co-Founder, President and Chief Medical Officer at ForSight Robotics, with over 20 years of experience in medical innovation.
ForSight Robotics aims to improve global access to high-quality ophthalmic care through their ORYOM™ hybrid intraocular robotic ophthalmic platform.
Dr. Nathan's background as both a physician and engineer influenced the vision for ForSight Robotics to revolutionize ophthalmic surgery.
The focus on ophthalmic surgery was chosen due to the high demand globally, with cataracts being a leading cause of vision impairment.
ForSight's ORYOM™ Platform offers 'superhuman' precision and scalability through AI and robotics, transforming surgical robotics with enhanced accuracy.
Success for ForSight includes reducing training time for surgeons, improving ergonomic comfort, and increasing surgical throughput to democratize access to surgeries.
The unique features of the ORYOM™ Platform include enhanced ergonomics, reduced procedure time, and a shorter learning curve for surgeons.
ForSight Robotics plans to expand access to ophthalmic surgeries globally, starting with the US market and aiming to address disparities in low-income countries.
The long-term vision of ForSight Robotics is to eradicate preventable blindness by scaling their robotic surgery platform to reach more patients globally.
Partnerships with hospitals, practitioners, and strategic investors play a crucial role in the adoption and growth of the ORYOM™ Platform.